Impact of Limited Cephalosporin Use on Prevalence of Methicillin-Resistant Staphylococcus aureus in the Intensive Care Unit

REFERENCES

• Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Hender-son TS, Tolson JS, Martone WJ. Methicillin-resistant Staphylo-coccus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992; 13: 582-6.
   Google Scholar
• Meyer E, Schwab F, Gastmeier P, Jonas D, Rueden H, Daschner FD. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Proj-ect SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units). Infect Control Hosp Epi-demiol 2006; 27: 146–54.
   PubMed Web of Science ®Google Scholar
• Lodise TP Jr, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect Control Hosp Epidemiol. 2003; 24: 655–61.
   PubMed Web of Science ®Google Scholar
• Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiol-ogy and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SEN-TRY study. J Clin Microbiol 2001; 39: 3727–32.
   PubMed Web of Science ®Google Scholar
• 2006 European Antimicrobial Resistance Surveillance Sys-tem. EARSS annual report 2006. Bilthoven, The Netherlands, 2007.
   Google Scholar
• Herwaldt LA. Control of methicillin-resistant Staphylococ-cus aureus in the hospital setting. Am J Med 1999; 106: 11S-18S
   Google Scholar
• Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA. Methicillin resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and manage-ment. Am J Med 1993; 94: 313–28.
   PubMed Web of Science ®Google Scholar
• Rice LB. Antimicrobial resistance in gram-positive bacte-ria. Am J Med 2006; 119: S11–519.
   PubMedGoogle Scholar
• Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. An-timicrobial drug use and methicillin-resistant Staphylococcus au-reus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10: 1432–41.
   Google Scholar
• Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28: 1062.
   PubMed Web of Science ®Google Scholar
• Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999–1005.
   PubMed Web of Science ®Google Scholar
• Harbarth S, Liassine N, Dharan S, Herrault P, Aucken-thaler R, Pittet D. Risk factors for persistent carriage of methi-cillin-resistant Staphylococcus aureus. Clin Infect Dis 2000; 31: 1380–5.
   PubMed Web of Science ®Google Scholar
• Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphy-lococcus aureus in hospitalized patients. Emerg Infect Dis 2003; 9: 1415–22.
   PubMed Web of Science ®Google Scholar
• Raymond DP, Pelletier SJ, Crabtree TD et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001; 29: 1103–1108.
   Google Scholar
• Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 2006; 27: 155–69.
   PubMed Web of Science ®Google Scholar
• World Health Organization collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification index with defined daily doses (DDDs). Oslo, Nor-way: The Center 2001.
   Google Scholar
• Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet In-fect Dis. 2007; 7: 282–8.
   PubMed Web of Science ®Google Scholar
• Carmeli Y, Castro J, Eliopoulos GM, Samore MH. Clini-cal isolation and resistance patterns of and superinfection with
   Google Scholar
• nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob Agents Chemother 2001; 45: 275–9.
   Google Scholar
• Hill DA, Herford T, Parratt D. Antibiotic usage and me-thicillin-resistant Staphylococcus aureus: an analysis of causality. J Antimicrob Chemother 1998; 42: 676–7.
   PubMed Web of Science ®Google Scholar
• Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Me-thicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999; 20: 31–6.
   PubMed Web of Science ®Google Scholar
• Campillo B, Dupeyron C, Richardet JP. Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epi-demiol Infect 2001; 127: 443–50.
   PubMed Web of Science ®Google Scholar
• Dziekan G, Hahn A, Thtine K Schwarzer G, Schafer K, Daschner FD, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000; 46: 263–70.
   Google Scholar
• Bassetti M, Cruciani M, Righi E, Rebesco B, Fasce R, Costa A, et al. Antimicrobial use and resistance among gram-negative bacilli in an Italian Intensive Care Unit (ICU). J Chemother 2006;18;261–267.
   PubMed Web of Science ®Google Scholar